Hengrui Therapeutics, Inc.
Get Full AccessDescription
- Princeton, NJ-based Hengrui Therapeutics, Inc. (HTI) is a U.S. biopharmaceutical company dedicated to developing and commercializing innovative drugs to address unmet medical needs. HTIs current therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss in the pipeline.
-
Headquarters:506 Carnegie Center Suite 102, Princeton, New Jersey, United States
More -
Phone Number: +1 609-423-2155
-
Website: https://www.hengruitherapeutics.com
-
Employees:9
-
Revenue:$1 - 10M
-
Legal Name:Hengrui Therapeutics, Inc.
-
Hengrui Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Hengrui Therapeutics, Inc.
-
Where are Hengrui Therapeutics, Inc.'s Headquarters?
Hengrui Therapeutics, Inc.'s Headquarters are in 506 Carnegie Center Suite 102,Princeton,New Jersey,United States
-
What is Hengrui Therapeutics, Inc.'s phone number?
Hengrui Therapeutics, Inc.'s phone number is +1 609-423-2155
-
What is Hengrui Therapeutics, Inc.'s official website?
Hengrui Therapeutics, Inc.'s official website is https://www.hengruitherapeutics.com
-
What is Hengrui Therapeutics, Inc.'s Revenue?
Hengrui Therapeutics, Inc.'s revenue is $1 - 10M
-
What is Hengrui Therapeutics, Inc.'s NAICS code?
Hengrui Therapeutics, Inc.'s NAICS code is 325412
-
How many employees are working in Hengrui Therapeutics, Inc.
Hengrui Therapeutics, Inc. has 9 employees
-
What is Hengrui Therapeutics, Inc.'s Industry?
Hengrui Therapeutics, Inc. is in the industry of Pharmaceuticals
-
Who is Hengrui Therapeutics, Inc.'s Vice President, Head Of Pharmacovigilance?
Hengrui Therapeutics, Inc.'s Vice President, Head Of Pharmacovigilance is Howard Snow

